PILL holdings
All 68 positions of Direxion Daily Pharmaceutical & Medical Bull 3X ETF.
Positions
68
Top 10 weight
261.2%
Effective holdings
6.4
1 / sum of squared weights
In stocks
74.1%
In bonds
0.0%
Outside the US
0.0%
Asset mix
Sectors
100% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | SPSIPH SWAP ASSET LEG | Derivative | 105.44% | $17M | 2,354 | |
| 2 | SPSIPH SWAP ASSET LEG | Derivative | 52.72% | $8.6M | 1,177 | |
| 3 | SPSIPH SWAP ASSET LEG | Derivative | 35.83% | $5.8M | 800 | |
| 4 | SPSIPH SWAP ASSET LEG | Derivative | 31.94% | $5.2M | 713 | |
| 5 | GOLDMAN FINL SQ TRSRY INST 506 | Derivative | 23.99% | $3.9M | 3,900,536 | US |
| 6 | DREYFUS GOVT CASH MAN INS | Derivative | 3.78% | $614K | 614,047 | |
| 7 | XERSXeris Biopharma Holdings, Inc. Common Stock | Equity | 1.99% | $324K | 31,757 | US |
| 8 | MANEVeradermics, Incorporated | Equity | 1.91% | $311K | 2,457 | US |
| 9 | PCRXPacira BioSciences, Inc. Common Stock | Equity | 1.91% | $311K | 8,533 | US |
| 10 | AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Equity | 1.72% | $279K | 14,194 | US |
| 11 | VTRSViatris Inc. Common Stock | Equity | 1.59% | $259K | 14,839 | US |
| 12 | LLYEli Lilly & Co. | Equity | 1.56% | $254K | 217 | US |
| 13 | CORTCorcept Therapeutics Inc. | Equity | 1.54% | $251K | 2,117 | US |
| 14 | LGNDLigand Pharmaceuticals Inc. | Equity | 1.54% | $251K | 850 | US |
| 15 | INDVIndivior Pharmaceuticals, Inc. Common Stock | Equity | 1.54% | $250K | 7,042 | US |
| 16 | ANIPANI Pharmaceuticals, Inc. | Equity | 1.53% | $249K | 3,463 | US |
| 17 | PRGOPERRIGO COMPANY PLC | Equity | 1.52% | $248K | 17,074 | |
| 18 | OGNOrganon & Co. | Equity | 1.51% | $246K | 17,911 | US |
| 19 | SUPNSupernus Pharmaceuticals, Inc. | Equity | 1.51% | $245K | 5,820 | US |
| 20 | PFEPfizer Inc. | Equity | 1.51% | $245K | 8,814 | US |
| 21 | ZTSZOETIS INC. | Equity | 1.50% | $244K | 3,340 | US |
| 22 | INVAInnoviva, Inc. Common Stock | Equity | 1.49% | $242K | 11,588 | US |
| 23 | OMEROmeros Corporation | Equity | 1.49% | $241K | 12,628 | US |
| 24 | PBHPrestige Consumer Healthcare Inc. | Equity | 1.48% | $241K | 5,028 | US |
| 25 | MRKMerck & Co., Inc. | Equity | 1.45% | $236K | 1,659 | US |
| 26 | JNJJohnson & Johnson | Equity | 1.45% | $235K | 916 | US |
| 27 | ELANElanco Animal Health Incorporated Common Stock | Equity | 1.44% | $234K | 10,396 | US |
| 28 | HRMYHarmony Biosciences Holdings, Inc. Common Stock | Equity | 1.43% | $233K | 5,883 | US |
| 29 | MAZEMaze Therapeutics, Inc. Common Stock | Equity | 1.41% | $229K | 8,863 | US |
| 30 | ETONEton Pharmaceutcials, Inc. Common Stock | Equity | 1.40% | $228K | 4,162 | US |
| 31 | RPRXRoyalty Pharma plc Class A Ordinary Shares | Equity | 1.40% | $227K | 4,041 | |
| 32 | BMYBristol-Myers Squibb Co. | Equity | 1.39% | $227K | 3,802 | US |
| 33 | COLLCollegium Pharmaceutical, Inc. Common Stock | Equity | 1.39% | $226K | 10,236 | US |
| 34 | JAZZJazz Pharmaceuticals, Inc. | Equity | 1.39% | $226K | 1,015 | |
| 35 | SEPNSepterna, Inc. Common Stock | Equity | 1.37% | $223K | 6,031 | US |
| 36 | EWTXEdgewise Therapeutics, Inc. Common Stock | Equity | 1.36% | $221K | 5,643 | US |
| 37 | DFTXDefinium Therapeutics, Inc. Common Shares | Equity | 1.36% | $220K | 6,445 | |
| 38 | TARSTarsus Pharmaceuticals, Inc. Common Stock | Equity | 1.31% | $214K | 2,958 | US |
| 39 | MBXMBX Biosciences, Inc. Common Stock | Equity | 1.27% | $207K | 3,892 | US |
| 40 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | Equity | 1.26% | $206K | 7,557 | US |
| 41 | HROWHarrow, Inc. Common Stock | Equity | 1.22% | $199K | 6,520 | US |
| 42 | AXSMAxsome Therapeutics, Inc | Equity | 1.22% | $198K | 1,163 | US |
| 43 | AMPHAmphastar Pharmaceuticals, Inc. | Equity | 1.17% | $190K | 7,376 | US |
| 44 | ZVRAZevra Therapeutics, Inc. Common Stock | Equity | 1.17% | $190K | 17,282 | US |
| 45 | TRVITrevi Therapeutics, Inc. Common Stock | Equity | 1.16% | $189K | 14,715 | US |
| 46 | NUVBNuvation Bio Inc. | Equity | 1.14% | $186K | 37,553 | US |
| 47 | ALMSAlumis Inc. Common Stock | Equity | 1.07% | $174K | 24,985 | US |
| 48 | ELVNEnliven Therapeutics, Inc. Common Stock | Equity | 1.07% | $173K | 4,262 | US |
| 49 | OCULOcular Therapeutix, Inc. | Equity | 0.99% | $160K | 21,347 | US |
| 50 | WVEWave Life Sciences Ltd. Ordinary Shares | Equity | 0.97% | $158K | 45,532 | |
| 51 | RAPPRapport Therapeutics, Inc. Common Stock | Equity | 0.95% | $155K | 5,183 | US |
| 52 | LBRXLB Pharmaceuticals Inc Common Stock | Equity | 0.94% | $153K | 4,426 | US |
| 53 | PAHCPhibro Animal Health Corporation Class A | Equity | 0.93% | $151K | 4,032 | US |
| 54 | CRMDCorMedix Inc. | Equity | 0.90% | $147K | 20,089 | US |
| 55 | AQSTAquestive Therapeutics, Inc. Common Stock | Equity | 0.90% | $147K | 30,874 | US |
| 56 | ANROAlto Neuroscience Inc. | Equity | 0.88% | $143K | 5,941 | US |
| 57 | PHATPhathom Pharmaceuticals, Inc. Common Stock | Equity | 0.84% | $137K | 19,189 | US |
| 58 | ACRSAclaris Therapeutics, Inc. | Equity | 0.63% | $102K | 26,961 | US |
| 59 | LQDALiquidia Corporation Common Stock | Equity | 0.61% | $99K | 3,542 | US |
| 60 | RLMDRelmada Therapeutics, Inc. Common Stock | Equity | 0.60% | $98K | 30,883 | US |
| 61 | AVLNAvalyn Pharma Inc. Common Stock | Equity | 0.58% | $95K | 3,679 | US |
| 62 | LXRXLexicon Pharmaceuticals, Inc. | Equity | 0.58% | $94K | 53,575 | US |
| 63 | EYPTEyePoint, Inc. Common Stock | Equity | 0.57% | $92K | 26,679 | US |
| 64 | ARVNArvinas, Inc | Equity | 0.55% | $90K | 11,949 | US |
| 65 | EOLSEvolus, Inc. Common Stock | Equity | 0.53% | $86K | 11,088 | US |
| 66 | CTNMContineum Therapeutics, Inc. Class A Common Stock | Equity | 0.48% | $78K | 5,947 | US |
| 67 | BIOABioAge Labs, Inc. Common Stock | Equity | 0.46% | $75K | 12,063 | US |
| 68 | ESPERION THERAPEUTICS INC | Derivative | 0.00% | $0 | 79,307 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Exit | AVDLAvadel Pharmaceuticals PLC | 1.43% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CORTCORCEPT THERAPEUTICS INC | 0.67% | 1.85% | +167.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | VTYXVentyx Biosciences Inc. | 1.16% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | OGNORGANON & COMPANY | 1.70% | 2.77% | +18.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | BIOABIOAGE LABS INC | — | 0.81% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | OMEROMEROS CORP | 0.87% | 1.64% | +69.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | LENZLenz Therapeutics Inc | 0.73% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | LBRXLB PHARMACEUTICALS INC | — | 0.64% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ALMSALUMIS INC | 0.62% | 1.25% | +127.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ARVNARVINAS INC | 1.44% | 0.81% | −14.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | NKTRNEKTAR THERAPEUTICS | 0.92% | 1.55% | −16.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | FULCFULCRUM THERAPEUTICS INC | — | 0.59% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | EOLSEvolus Inc | 0.52% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | LQDALIQUIDIA CORP | 1.85% | 1.36% | −10.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | TRVITREVI THERAPEUTICS INC | 1.06% | 1.54% | +25.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | OCULOCULAR THERAPEUTIX INC | 0.85% | 1.32% | +71.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | ANROALTO NEUROSCIENCE INC | — | 0.43% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | DFTXDEFINIUM THERAPEUTICS INC | 1.95% | 1.57% | −29.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | TBPHTHERAVANCE BIOPHARMA INC | 0.66% | 1.02% | +97.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | EWTXEDGEWISE THERAPEUTICS INC | 1.69% | 1.34% | −19.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | MRKMERCK & COMPANY INC | 1.61% | 1.26% | −11.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | NUVBNUVATION BIO INC | 0.95% | 1.30% | +80.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | PCRXPACIRA BIOSCIENCES INC | 1.17% | 1.49% | +16.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | JNJJOHNSON & JOHNSON | 1.57% | 1.27% | −10.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | HROWHARROW INC | 1.17% | 1.47% | +43.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ESPRESPERION THERAPEUTICS INC | 1.26% | 1.00% | +50.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | RAPPRAPPORT THERAPEUTICS INC | 1.27% | 1.01% | −27.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | WVEWAVE LIFE SCIENCES LTD | 0.91% | 0.67% | +51.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | VTRSVIATRIS INC | 1.61% | 1.43% | −12.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | XERSXERIS BIOPHARMA HOLDINGS INC | 1.52% | 1.35% | +21.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | PHATPHATHOM PHARMACEUTICALS INC | 1.16% | 1.01% | +20.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | PAHCPHIBRO ANIMAL HEALTH CORP | 1.33% | 1.20% | −23.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ZVRAZEVRA THERAPEUTICS INC | 0.88% | 0.75% | −14.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | HRMYHARMONY BIOSCIENCES HOLDINGS INC | 1.33% | 1.45% | +44.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | RPRXROYALTY PHARMA PLC | 1.56% | 1.44% | −13.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | PRGOPERRIGO COMPANY PLC | 1.50% | 1.62% | +45.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CRMDCORMEDIX INC | 0.84% | 0.95% | +30.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | AMPHAMPHASTAR PHARMACEUTICALS INC | 1.24% | 1.13% | +23.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | LGNDLIGAND PHARMACEUTICALS INC | 1.49% | 1.39% | −12.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | SEPNSEPTERNA INC | 0.60% | 0.69% | +27.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | TARSTARSUS PHARMACEUTICALS INC | 1.13% | 1.22% | +22.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CRNXCRINETICS PHARMACEUTICALS INC | 1.48% | 1.40% | +37.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | COLLCOLLEGIUM PHARMACEUTICAL INC | 1.34% | 1.27% | +44.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | INDVINDIVIOR PHARMACEUTICALS INC | 1.43% | 1.50% | +14.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ANIPANI PHARMACEUTICALS INC | 1.43% | 1.39% | +13.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | EYPTEYEPOINT INC | 1.16% | 1.18% | +18.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.